NuVasive Announces Location for New Manufacturing Facility

NuVasive Inc. is expanding. Company executives have selected a site in West Carrollton, Ohio, for the build-out of its new medical device facility dedicated to spinal implant and instrument manufacturing. As first announced in August 2015, this new facility will support the firm’s efforts to increase its internal manufacturing capabilities alongside its existing manufacturing facility in Dayton, Ohio, and enhance its focus on operational excellence.

NuVasive has entered into an agreement to acquire the manufacturing site and plans to invest approximately $45 million over the next 24 months to build-out and equip the new facility. The 160,000- square-foot facility is currently scheduled to begin commercial scale production by year-end 2016. Subject to customary closing conditions, NuVasive expects to complete the acquisition of the site by the end of the year. NuVasive also is in the process of finalizing a package of incentives that reflects a continued partnership between the company and the state of Ohio.

“We are happy to announce that we have selected a site in West Carrollton, Ohio, as the location for our new medical device manufacturing facility,” NuVasive Chairman/CEO Gregory T. Lucier said. “The site selection and subsequent build-out is a major step forward in our efforts to enhance our manufacturing presence in the United States to support the self-manufacture of nearly 100 percent of select spinal products and instruments. With this new facility and our longer-term plans to also expand our manufacturing footprint globally, we expect to increase customer responsiveness, dramatically improve inventory turns and speed up design time velocity to more efficiently meet the growing demand for our innovative spine technology.”

“Our Ohio workforce is a critical part of our success and we are excited to expand our footprint and provide additional opportunities within the state. We greatly appreciate the support and cooperation of the Dayton Development Coalition and JobsOhio, as well as officials from both Montgomery County and the city of West Carrollton during the site selection process,” Lucier continued. “I would like to personally thank Gov. John R. Kasich and his office for their commitment to support incentives for NuVasive as we build out the new facility and train our expanded pool of employees who will support our growth in the region. We look forward to building on this partnership and investing in the local community for years to come.”

When at full scale, the new facility is expected to employ approximately 300 full-time, high-tech positions, including engineers and skilled machinists, as well as process development and validation specialists who will work with NuVasive’s research and development teams to optimize and accelerate product launches. The new facility will house state-of-the-art equipment, including approximately 100 computer numerical control (CNC) machine tools and CMM inspection equipment, as well as clean-room operations.

“After an extensive search, we are thrilled NuVasive chose to expand their U.S. manufacturing asset in the Dayton region,” said Jeff Hoagland, president and CEO of the Dayton Development Coalition. “NuVasive’s investments in this new facility will retain and create hundreds of jobs for the region and support future development. Working together collaboratively with NuVasive and our community partners provided the support the Company needed to stay in the Dayton region and continue to grow.”

“NuVasive’s plan to remain in the Dayton region will enable our community to keep roughly a hundred existing jobs with plans to add nearly 200 more,” added Debbie Lieberman, Montgomery County Commission president. “The area’s supply of a qualified workforce, various incentives and the efforts from a partnership between JobsOhio, the Dayton Development Coalition, Montgomery and Greene Counties and various local municipalities, have proven to be a deciding factor in the company’s decision to remain in the region.”

Headquartered in San Diego, Calif., NuVasive develops minimally disruptive surgical products and procedurally-integrated solutions for the spine. NuVasive offers a spine portfolio of more than 90 products developed to improve spine surgery and patient outcomes. The company’s principal procedural solution is its Maximum Access Surgery, or MAS, platform for lateral spine fusion. MAS was designed to provide safe, reproducible, and clinically proven outcomes, and is a highly differentiated solution with fully integrated neuromonitoring, customizable exposure, and a broad offering of application-specific implants and fixation devices designed to address a variety of pathologies.